D-ribose
Also called: ribose
A naturally occurring five-carbon sugar (pentose). The ingredient assessed by EFSA is made by fermentation using a transketolase-deficient strain of Bacillus subtilis and is intended for foods, food supplements and certain foods for specific groups.
- Category
- Other
- Forms
- D-ribose (taken as powder or capsules in trials)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-30
Class 2 Moderately studied in people. Five randomized trials of D-ribose alone were found: three in healthy exercising men (two in 2003, one in 2020), a crossover in 15 heart-failure patients (2003) and the D-ribose arm of a 216-patient heart-failure trial (2022). No systematic review stating a count was found. [7]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CMuscles and exercise3 topics
CHeart and blood vessels1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Repeated sprint performance | C | A randomized crossover study in men (32 g over 36 hours versus cellulose) found ribose did not produce reproducible increases across six cycle sprints; authors concluded no consistent or substantial effect. [4] |
| Muscle soreness after plyometric exercise | C | In 21 untrained male students given 15 g doses around exercise, soreness fell versus their first session, and creatine kinase, LDH, myoglobin and malondialdehyde at 24 h were lower than with placebo; strength did not differ. [5] |
| Heart function and quality of life in heart failure | C | A double-blind randomized crossover study in 15 patients with coronary disease and congestive heart failure (3 weeks per period) reported better diastolic echocardiography measures and quality of life with D-ribose than placebo. [7] |
| Exercise tolerance in McArdle disease | C | A double-blind placebo-controlled crossover trial in 5 patients (60 g/day for 7 days) found no benefit on exercise tolerance; patients did not like taking the ribose. [8] |
Main constituents: D-ribose, a pentose carbohydrate [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- 10 g/day for 5 days (Kreider 2003, trained men). [6]
- 15 g/day for 12 weeks in heart failure with preserved ejection fraction (factorial trial with ubiquinol). [9]
Upper limits
- EFSA (2018) defined an acceptable intake of 36 mg/kg body weight per day for the general population, based on a NOAEL of 3.6 g/kg body weight per day from a subchronic rat study and accounting for possible sensitivity to hypoglycemia; it set 70 mg/kg body weight per day as the adult NOAEL for hypoglycemia. [2]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
Regulatory status
- EU: EFSA (2018) found D-ribose safe up to 36 mg/kg body weight per day; a December 2018 EFSA statement concluded it is safe under the applicant's new proposed conditions of use. [3]
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [10]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- D-ribose Monosaccharide (pentose sugar) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming ribose (earliest NDI 24 submitted 1997-10-28; most recent NDI 73 submitted 2000-01-21); 3 more entries name D-ribose-L-cysteine, a different compound. Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
- Teitelbaum JE, Johnson C, St Cyr J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med 2006;12(9):857-62 (PMID 17109576), 2006-11. pubmed.ncbi.nlm.nih.gov
Sources
- Teitelbaum JE, Johnson C, St Cyr J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med 2006;12(9):857-62 (PMID 17109576), 2006-11. pubmed.ncbi.nlm.nih.gov
- EFSA NDA Panel. Safety of d-ribose as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J 2018;16(5):e05265 (PMID 32625902), 2018-05-31. pubmed.ncbi.nlm.nih.gov
- EFSA NDA Panel. Statement on the safety of d-ribose. EFSA J 2018;16(12):e05485 (PMID 32625778), 2018-12-13. pubmed.ncbi.nlm.nih.gov
- Berardi JM, Ziegenfuss TN. Effects of ribose supplementation on repeated sprint performance in men. J Strength Cond Res 2003;17(1):47-52 (PMID 12580655), 2003-02. pubmed.ncbi.nlm.nih.gov
- Cao W, et al. Effect of D-ribose supplementation on delayed onset muscle soreness induced by plyometric exercise in college students. J Int Soc Sports Nutr 2020;17(1):42 (PMID 32778175), 2020-08-10. pubmed.ncbi.nlm.nih.gov
- Kreider RB, et al. Effects of oral D-ribose supplementation on anaerobic capacity and selected metabolic markers in healthy males. Int J Sport Nutr Exerc Metab 2003;13(1):76-86 (PMID 12660407), 2003-03. pubmed.ncbi.nlm.nih.gov
- Omran H, et al. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. Eur J Heart Fail 2003;5(5):615-9 (PMID 14607200), 2003-10. pubmed.ncbi.nlm.nih.gov
- Steele IC, Patterson VH, Nicholls DP. A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease. J Neurol Sci 1996;136(1-2):174-7 (PMID 8815168), 1996-03. pubmed.ncbi.nlm.nih.gov
- Pierce JD, et al. Effects of ubiquinol and/or D-ribose in patients with heart failure with preserved ejection fraction. Am J Cardiol 2022;176:79-88 (PMID 35644694), 2022-08-01. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.